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Uptake, Biodistribution, and Time Course of Naked Plasmid
DNA Trafficking After Intratumoral In Vivo Jet Injection
W. WALTHER,1 T. MINOW,2 R. MARTIN,1 I. FICHTNER,1 P.M. SCHLAG,2 and U. STEIN1
ABSTRACT
Nonviral jet injection is an applicable technology for in vivo gene transfer of naked DNA. However, little is
known about the biodistribution and clearance of jet-injected DNA, or about its localization within tissue and
cells. Therefore, in this study we analyzed the intratumoral and systemic biodistribution of jet-injected naked
DNA in human colon carcinoma-bearing NCr-nu/nu mice, which were jet-injected with the pCMV plasmid
DNA. Intratumoral and systemic plasmid DNA biodistribution was analyzed 5, 10, 20, and 40 min and 3, 6,
24, 48, and 72 hr after jet injection, using quantitative real-time polymerase chain reaction. In the tumors, a
rapid drop in naked DNA load within 24 hr of jet injection was shown. Detailed analysis of intratumoral dis-
tribution of rhodamine-labeled DNA revealed the presence of plasmid DNA within tumor cells 5 min after jet
injection and further accumulation of significant DNA amounts in the cell nuclei 30 to 60 min after jet in-
jection. In the blood, DNA amounts rapidly dropped within 10 to 40 min of jet injection to less than 0.001 pg
of plasmid per 250 ng of tissue DNA and only minimal plasmid DNA dissemination was detected in liver, lung,
spleen, kidney, and ovaries, which was cleared 3 to 6 hr after jet injection. By contrast, in heart, bone mar-
row, and brain almost no plasmid DNA was detectable.
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OVERVIEW SUMMARY
In this study jet injection was used for the direct gene trans-
fer of naked DNA into tumors to evaluate the biodistribu-
tion of plasmid DNA. The intratumoral plasmid DNA load
and the systemic appearance of the DNA was analyzed by
quantitative real-time polymerase chain reaction 5, 10, 20,
and 40 min and 3, 6, 24, 48, and 72 hr after jet injection.
The results indicated a rapid decrease in plasmid DNA con-
centration in the tumors. Jet injection of rhodamine-la-
beled DNA revealed that as early as 5 min after in vivo jet
injection plasmid DNA appears in the cytoplasm and in the
nuclei of tumor cells, indicating the rapid intracellular and
nuclear entry of jet-injected plasmid DNA. Regarding sys-
temic biodistribution, the highest amounts of plasmid DNA
were detected in the blood 5 min after intratumoral jet in-
jection, and rapidly dropped within 10 to 40 min. By com-
parison, only minimal amounts of plasmid DNA were de-
tected in peripheral organs, which were cleared within 3 to
6 hr.
INTRODUCTION
IN GENE THERAPY, including cancer gene therapy, the major-ity of delivery systems employed are of retroviral or adeno-
viral origin (Walther and Stein, 2000). Because viral vectors
have different disadvantages, such as provocation of unwanted
immune responses, virus-associated toxicities, viral recombi-
nation, or insertional mutagenesis, many investigators have
shifted their attention toward nonviral transfer systems, espe-
cially if timely restricted expression of the transgene is at-
tempted (Niidome and Huang, 2002). The use of naked DNA
is particularly attractive, because of its low immunogenicity,
minimal or absent toxicity and its simplicity of use. Besides the
simple needle and syringe injection, most applications of naked
DNA are associated with the employment of physical transfer
technologies for the introduction of naked DNA into the tar-
geted tissue. Such physical technologies include in vivo elec-
troporation, focused ultrasound, particle bombardment (biolis-
tic transfer), or jet injection (Li and Huang, 2000; Somiari et
al., 2000; Niidome and Huang, 2002). Some of these tech-
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nologies have entered the level of clinical testing in gene ther-
apy protocols.
We and others have demonstrated that efficient gene trans-
fer of naked DNA into tumors can be achieved in vivo, if jet
injection technology is used (Walther et al., 2001). Jet injec-
tion-mediated intratumoral gene transfer of reporter gene-ex-
pressing plasmids or therapeutic gene-expressing constructs led
to the expression of these genes in various tumor models, us-
ing only small amounts of naked DNA (Walther et al., 2001,
2002). Similar results have been reported when muscle tissue
was targeted for jet injection gene transfer (Furth et al., 1992,
1995; Cartier et al., 2000).
Apart from the fact that jet injection gene transfer is ef-
fective for introducing naked DNA into tumors in vivo, there
is a need to analyze and understand the fate of naked DNA
applied to tumors. There are various reports dealing with the
biodistribution of transduced naked DNA after needle injec-
tion, in vivo electrotransfer, or biolistic transfer (Dupuis et al.,
2000; Pilling et al., 2002; Cappelletti et al., 2003). However,
nothing is known about the fate of naked DNA in vivo if ap-
plied by jet injection. We therefore analyzed the time-depen-
dent biodistribution of jet-injected plasmid DNA in tumors
and the systemic dissemination of naked DNA, using quanti-
tative real-time polymerase chain reaction (PCR). This type
of real-time PCR is a sensitive method allowing quantitative
detection of small amounts of plasmid DNA jet-injected into
tumors or of plasmid disseminated to the blood circulation or
to other organs. Several reports have demonstrated the use-
fulness of this method for biodistribution studies of naked
DNA gene transfer (Hackett et al., 2000; Maruyama et al.,
2002; Rose et al., 2002). In addition, we employed quantita-
tive real-time reverse transcription (RT)-PCR to analyze re-
porter gene mRNA expression in jet-injected tumors and to
evaluate the potential transcriptional activity of disseminated
plasmid in other organs.
We further analyzed the path taken by plasmid DNA within
the cells of jet-injected tumors to localize cellular distribution
in more detail by confocal fluorescence microscopy. Using this
approach, we were able to provide more insight into the local-
ization of jet-injected naked DNA at the tissue and cellular lev-
els during the time course of intratumoral DNA clearance.
MATERIAL AND METHODS
Preparation of plasmid DNA
The pCMV plasmid (Clontech, Palo Alto, CA) was used
for expression of the bacterial -galactosidase gene (lacZ). The
plasmid was amplified in One Shot competent Escherichia coli
bacteria (Invitrogen, Groningen, The Netherlands), purified
with a JETSTAR purification kit (GENOMED, Löhne, Ger-
many), and dissolved in phosphate buffer (150 mM
Na2HPO4/NaH2PO4; pH 7.0) to a final concentration of 1 g
of DNA per microliter. This plasmid DNA was used for intra-
tumoral in vivo jet injection.
To study the tissue and intracellular localization of plas-
mid DNA after jet injection, the rhodamine-labeled pGene-
GRIP plasmid (Gene Therapy Systems, San Diego, CA) was
used.
Intratumoral in vivo jet injection of naked pCMV
plasmid DNA
For the nonviral in vivo gene transfer, female NCr-nu/nu mice
xenotransplanted with patient-derived human colon carcinoma
Colon5737 cells were used (Fichtner et al., 2004). When tumors
reached a size of approximately 6  6 mm the tumor-bearing
animals were anesthetized and received five intratumoral jet in-
jections of pCMV plasmid DNA through the skin, using a
Swiss Injector prototype (Electro Medical Systems, Nyon,
Switzerland) at a pressure of 3.0 bar, a condition optimized in
previous studies for in vivo gene transfer (Walther et al., 2002).
These jet injections were applied at five different sites in the tu-
mor (see Fig. 4B). The respective control animals were jet-in-
jected with saline. Each jet injection applied 10 l of plasmid
solution containing naked plasmid DNA at 1 g/l. Therefore,
each animal received a total dose of 50 g of pCMV plasmid
DNA. Five, 10, 20, and 40 min and 3, 6, 24, 48, and 72 hr af-
ter jet injection, animals (n  3 per time point) were killed and
tumors were removed and snap frozen in liquid nitrogen for fur-
ther analysis. Furthermore, whole blood, liver, lung, heart, bone
marrow, spleen, kidney, ovaries, and brain were removed and
shock frozen in liquid nitrogen for further analysis.
For intratumoral and cellular localization of rhodamine-labeled
plasmid DNA, animals received five jet injections of pGeneGRIP
plasmid-containing solution. The animals were killed 5, 30, and
60 min (n  2 animals per time point) after jet injection, and tu-
mors were removed and shock frozen for further analysis.
Quantitative real-time PCR analysis of pCMV
plasmid DNA distribution in jet-injected animals
For detection of pCMV plasmid DNA, cellular DNA was
isolated from serial cryosections (20 m) of tumors and the re-
spective organs, using a QIAamp DNA mini kit (Qiagen, Va-
lencia, CA).
Each quantitative real-time PCR (95°C for 30 sec; 45 cycles
of 95°C for 10 sec, 62°C for 10 sec, and 72°C for 10 sec) was
performed with 250 ng of cellular DNA in a LightCycler reac-
tion (LightCycler DNA master hybridization probes kit; Roche
Diagnostics, Mannheim, Germany) in duplicate per sample. For
the pCMV plasmid a 127-bp amplicon (forward primer, 5-
AAGCAAAAAAGAAGTCACCATG-3; fluorescein isothio-
cyanate [FITC]-labeled probe, 5-CGGTCTGGGAGGCATT-
GGT-3-FITC; LCRed640-labeled probe, LCRed640-5-GG-
ACACCAGCAAGGAGCTGCT-3; reverse primer, 5-GTAA-
AACGACGGGATCGC-3) was produced, which was detected
by the gene-specific fluorescein- and LCRed640-labeled hy-
bridization probes (syntheses of primers for pCMV: BioTeZ,
Berlin, Germany; syntheses of probes for lacZ: TIB MOLBIOL,
Berlin, Germany) (Fig. 1A).
pCMV concentrations in 250 ng of cellular DNA were 
calculated by comparison with a “spiked” standard curve of
pCMV plasmid. For spiking, pCMV plasmid DNA was se-
rially diluted (0.005, 0.05, 0.5, 5, 10, 30, 50, and 80 ng in du-
plicate) in 250 ng of cellular DNA isolated from the human colon
carcinoma cell line SW480 or from the organs of test animals.
Each organ-based spiked standard curve was generated in
parallel in each real-time PCR run (Fig. 2A–C) to ensure the
accuracy of DNA quantitation. The quality of PCR products
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was evaluated for each run by the corresponding melting curves
as shown in Fig. 2E.
Quantitative real-time RT-PCR analysis of LacZ
expression in jet-injected tumors
Total RNA from cryosections of tumors or organs was iso-
lated by the TRIzol method according to the manufacturer’s in-
structions (Life Technologies, Karlsruhe, Germany). To prevent
potential contamination with plasmid DNA, all RNA probes
were treated with RNase-free DNase I (Roche Diagnostics). The
reverse transcriptase (RT) reaction was performed with 30 ng
of total RNA isolated from tumor tissues or respective organs
(murine leukemia virus [MuLV] reverse transcriptase;
PerkinElmer, Weiterstadt, Germany).
Quantitative real-time PCR (95°C for 30 sec; 45 cycles of
95°C for 10 sec, 62°C for 10 sec, and 72°C for 10 sec) was done
with the LightCycler (LightCycler DNA master hybridization
probes kit; Roche Diagnostics). Expression of the lacZ gene was
determined in duplicate for each sample. For lacZ a 101-bp am-
plicon (forward primer, 5-CCGTTGATGTTGAAGTGG-3;
FITC-labeled probe, 5-GCGCGGATTGGCCTGAACT-3-
FITC; LCRed640-labeled probe, LCRed640-5-CAGCTG-
GCGCAGGTAGCAGA-3; reverse primer, 5-CTAATCC-
GAGCCAGTTTACCC-3) was produced,which was detected
by gene-specific fluorescein- and LCRed640-labeled hybridiza-
tion probes (syntheses of primers for lacZ: BioTeZ; syntheses
of probes for lacZ: TIB MOLBIOL) (Fig. 1B).
Calibrator cDNA derived from a stably pCMV-transduced
LacZ-expressing cell clone (human colon carcinoma cell line
SW480) was employed in serial dilutions (3, 10, 30, 100, 300,
and 500 ng in duplicate) simultaneously in each run and served
as internal standard for LacZ calculations. LacZ expression
(mean of the duplicates) for each tumor sample was calculated
and expressed as relative fold LacZ mRNA expression in rela-
tion to the calibrator cell line. For all RT-PCR runs the quality
of corresponding PCR products was evaluated on the basis of
melting curves.
Isolation of nuclear DNA from jet-injected 
tumor tissues
For the isolation of nuclei from jet-injected tumor tissues,
tumors were cryosectioned (20 m) and 10 to 20 sections were
collected in an Eppendorf tube. The sections were homogenized
in 1 ml of lysis buffer (40 mM sodium citrate, 1% Triton 
X-100) on ice. After a 5-min incubation on ice the supernatant
was transferred to another tube and centrifuged at 1000 rpm for
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FIG. 1. Schematic representation of primer
and probe positions for quantitative real-time
PCR (top) and real-time RT-PCR (bottom). For
the PCR the forward primers bind to sequences
of the pCMV plasmid backbone located 5 up-
stream from the ATG of the lacZ gene to ensure
plasmid specificity of the PCR analysis of plas-
mid distribution in the tumor and in the organs
of jet-injected animals. The real-time PCR cre-
ates an amplicon of 127 bp. For the real-time
RT-PCR the primers are designed to bind within
the cDNA sequence derived from the LacZ
mRNA, which leads to an amplicon of 101 bp.
CMV prom, cytomegalovirus promoter; LacZ,
-galactosidase gene; fwd, forward primer; rev,
reverse primer; FITC, FITC-labeled probes;
LCRed, LCRed640-labeled probes.
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5 min. The nuclear pellet was washed three times to remove
potential cytoplasmic contaminations (see Fig. 6C). To the nu-
clear pellet (quality of nuclear preparations was evaluated by
light microscopy; see Fig. 6C) 1 ml of TRIzol (Invitrogen) was
added and the mixture was incubated for 5 min at room tem-
perature. Thereafter, 0.2 ml of chloroform was added and the
mixture was vortexed, incubated for 3 min at room tempera-
ture, and centrifuged at 14,000 rpm at 4°C. After transfer of the
supernatant to another tube, 0.5 ml of isopropanol was added
and the mixture was incubated for 10 min and centrifuged at
14,000 rpm for 10 min at 4°C. The DNA pellet was washed
with 70% ethanol and then resuspended in 20 l of TE buffer
(pH 7.0). This nuclear DNA was treated with DNase-free RNase
and subjected to quantitative real-time PCR analysis for the
BIODISTRIBUTION OF JET-INJECTED DNA 615
FIG. 2. Representative “spiked” standard curve of pCMV plasmid for the quantitation of plasmid DNA in tumor tissue and
organs. For spiking, pCMV plasmid DNA was serially diluted (0.005, 0.05, 0.5, 5, 10, 30, 50, and 80 ng of plasmid DNA) in
250 ng of cellular DNA isolated from the human colon carcinoma cell line SW480. (A) Representative quantitative real-time
PCR (LightCycler) of the spiked standard curve, where each plasmid concentration is determined in duplicate. (B) Correspond-
ing linear regression of the standard curve and the intrarun variation (6%). (C) Corresponding melting curves. (D) A repre-
sentative real-time PCR run and the corresponding melting curves (E) for detection of pCMV plasmid DNA in the tumor of
animal 1, 5 min after jet injection, which is also shown in Fig. 4C.
mid DNA by jet injection. We analyzed the DNA load at de-
fined time points after jet injection to evaluate the amount of
DNA present within each tumor and to analyze the time course
of DNA clearance after jet injection. To accomplish this, we
used real-time PCR to quantitate the amount of DNA (see Fig.
2D and E), which was normalized to a standard curve gener-
ated by real-time PCR (see Fig. 2A–C) using serial dilutions of
spiked pCMV plasmid DNA as described.
Figure 3 depicts the mean (n  3) total plasmid DNA load
in tumors 5, 10, 20, and 40 min and 3, 6, 24, 48, and 72 hr af-
ter jet injection. As shown in Fig. 3, the highest DNA amounts
(about 12 g) were detected 5 min after intratumoral jet injec-
tion, representing 24% of the initial dose of 50 g of jet-in-
jected naked plasmid DNA. In the relatively short period of 10
min after jet injection a rapid drop in DNA load in the tumors
was observed. This phase of rapid DNA clearance was followed
by a phase of slower elimination rate, which reached a mini-
mum of 0.56–0.04 g of plasmid DNA load 24 to 72 hr after
jet injection. This finding is a strong indication that within the
first 5 min after jet injection more than 70% of the initial DNA
is cleared from the tumor tissue, which might be attributed to
“washout” by the blood flow in the well-vascularized tumors
and also by processes of DNA degradation within the tumor.
To obtain more detailed insight concerning the biodistribu-
tion of plasmid DNA within tumors, a consecutive series of
cryosections covering an entire tumor was analyzed for DNA
load at each time point (Fig. 4A). As shown in Fig. 4C and D,
in representative tumors from three different animals 5 min and
24 hr after jet injection, a heterogeneous distribution of plas-
mid DNA was determined. This is reflected by the variations
seen in DNA concentration in the various tumor fractions; this
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FIG. 3. Analysis of time-dependent intratumoral DNA load, that is, jet-injected pCMV plasmid. Columns represent mean to-
tal plasmid load in three different animals for each time point after jet injection of the initial dose of 50 g of DNA per tumor.
Quantification of plasmid DNA was performed in duplicate by real-time PCR (LightCycler), using a spiked plasmid DNA stan-
dard curve for each quantification analysis. (Error bars represent the SD.)
presence of pCMV in the nuclei. This real-time PCR was per-
formed in duplicate for all reactions.
Confocal laser scanning microscopy
For confocal laser scanning microscopy, pGeneGRIP jet-in-
jected tumors were removed 5, 30, and 60 min after jet injection,
cryosectioned (13 m), and fixed in 3% formaldehyde for 10
min, dehydrated with acetone, and permeabilized with 0.1% Tri-
ton. After thorough washing in phosphate-buffered saline (PBS),
nuclei were stained for 1 min with TO-PRO-3 (Invitrogen Mo-
lecular Probes, Eugene, OR), washed with PBS, and dehydrated
with 96% ethanol. The sections were then covered with Fara-
mount (Dako, Carpinteria, CA) and evaluated with an LSM 510
META laser scanning microscope (Carl Zeiss, Jena, Germany)
and analyzed with LSM 5 Image Examiner software (Carl Zeiss).
Rhodamine was excited with laser light at 488 nm and TO-PRO-
3 was excited with laser light at 647 nm. The fluorescence sig-
nals were detected with a dichroic beamsplitter UV/488/563/633
and the emission filter BP565-615 (rhodamine) or LP 650 (TO-
PRO-3). In z stacks the slice thickness was 0.4 m and overlap-
ping slices were used for three-dimensional reconstructions with
thresholds according to the labels in the images.
RESULTS
Intratumoral jet injection and clearance of 
plasmid DNA in tumor
To evaluate the biodistribution of jet-injected naked DNA in
tumor tissue, animals received a total of 50 g of pCMV plas-
might be due to the physical characteristics of the tissue-pene-
trating jet (Fig. 4A). However, for both representative time
points, plasmid DNA was detected throughout the entire tumor
tissue (represented by the six cryosection fractions), although
at different concentration levels (Fig. 4C and D). In fact, sim-
ilar patterns of plasmid distribution were also shown for all
other time points, including 48 and 72 hr after jet injection (data
not shown).
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FIG. 4. Detailed real-time PCR analysis of intratumoral biodistribution of pCMV plasmid DNA 5 min and 24 hr after jet in-
jection. (A) Schematic representation of tumor fractionation for real-time PCR analysis after jet injection: fractions 1 to 6 were
generated by cryosectioning of each tumor, in order to represent the entire tumor. (B) The five sites of jet injections (indicated
by arrows) of a tumor-bearing animal. (C) Intratumoral plasmid distribution in three different animals 5 min after jet injection.
(D) Intratumoral plasmid distribution in three different animals 24 hr after jet injection. The amounts of plasmid DNA shown
were detected in 250 ng of tumor DNA and were determined in duplicate for each time point.
FIG. 5. Distribution of rhodamine-labeled pGeneGRIP plasmid DNA in tumor tissue after intratumoral jet injection, as ana-
lyzed by fluorescence microscopy. (A–C) Tissue distribution of rhodamine-labeled DNA (orange/red) 5, 30, and 60 min, re-
spectively, after jet injection. Plasmid DNA is localized within the intercellular space and within the tumor cells (indicated by
arrows). Cell nuclei are stained blue. Microphotographs on the left are taken at an original magnification of 60, those on the
right at an original magnification of 100.
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Cellular localization of rhodamine-labeled plasmid
DNA after intratumoral jet injection
To analyze at the tissue and cellular levels the fate of naked
DNA jet-injected into tumor, we used rhodamine-labeled
pGeneGRIP plasmid DNA for in vivo jet injection. Five, 30,
and 60 min after jet injection tumors were analyzed for local-
ization of the labeled DNA, using fluorescence microscopy and
confocal laser scanning microscopy.
Figure 5 depicts the pattern of plasmid distribution in jet-in-
jected tumors. Plasmid DNA is localized mainly in the inter-
cellular space; some can also be found within the tumor cells.
The microphotographs in Fig. 5 demonstrate the inhomoge-
neous spread pattern of plasmid DNA, which was generated by
the jet force in the tissue and that is in agreement with data ob-
tained by real-time PCR analysis (see Fig. 4).
To obtain a more detailed picture of plasmid DNA localiza-
tion at the cellular level, tumors were analyzed by confocal scan-
ning laser microscopy. The microphotographs in Fig. 6A show
that as soon as 5 min after jet injection plasmid DNA was de-
tected within tumor cells. Thirty to 60 min after jet injection a
further increase in intracellular and perinuclear accumulation of
labeled DNA was seen. More interestingly, clear nuclear pene-
tration of labeled plasmid DNA was detectable 30 and 60 min
after jet injection (Fig. 6A). To evaluate whether such nuclear
localization had already initiated as early as 5 min after jet in-
jection, three-dimensional (z stack) analysis of the confocal laser
scanning images was performed. As shown in Fig. 6B, small
proportions of rhodamine-labeled plasmid DNA were localized
in the cell nuclei of tumor tissue 5 min after jet injection.
To quantitatively complement these findings by confocal
laser scanning microscopy, DNA from cell nuclei was isolated
from the same tumor tissues shown in Fig. 6A and quantitative
real-time PCR was performed to detect plasmid DNA. The pu-
rity of nuclear preparations was evaluated by light microscopy
and by control of the washing buffer of the nuclear pellet for
the presence of plasmid contamination (Fig. 6C). The results
depicted in Fig. 6D support our previous observation that, in-
deed, 5 min after jet injection small amounts of plasmid DNA
(0.06 pg of plasmid DNA per 250 ng of nuclear DNA) were
detectable in the cell nuclei. Over time a rapid nuclear plasmid
accumulation was observed, reflected by an 13-fold increase in
DNA load from 0.21 pg of plasmid DNA per 250 ng of nuclear
DNA 30 min after jet injection to 2.8 pg of plasmid DNA per
250 ng of nuclear DNA 60 min after jet injection. These data
provide evidence that jet injection permits rapid intratumoral
and, more importantly, intracellular penetration of naked plas-
mid DNA associated with almost simultaneous nuclear local-
ization of small proportions of jet-injected DNA.
Systemic biodistribution of plasmid DNA after
intratumoral jet injection
Besides the analysis of the distribution of plasmid DNA
within tumors, it is of crucial importance to monitor the sys-
temic biodistribution of applied naked DNA. To accomplish
this, we analyzed by real-time PCR samples of blood, liver,
lung, kidney, spleen, ovary, heart, brain, and bone marrow from
all treated animals at all time points after jet injection. This
quantitative analysis was performed to provide information
about the time-dependent biodistribution in these particular or-
gans and the clearance of the DNA. Figure 7 shows the results
for systemic plasmid biodistribution after intratumoral jet in-
jection. Although at much lower plasmid DNA concentrations
in the various organs (240-fold lower compared with tumors),
systemic leakage of the intratumorally jet-injected DNA was
seen. Five minutes after intratumoral jet injection the highest
level of plasmid DNA was observed in the blood of the ani-
mals (Fig. 7A). However, the plasmid concentration rapidly
dropped from about 48 to less than 5 pg of plasmid DNA per
250 ng of blood DNA within 20 min of jet injection. This de-
cline in plasmid DNA in the blood of the animals was paral-
leled by the increase in plasmid DNA in the various organs,
particularly in liver, lung, and kidney and at a much lower level
in ovaries, spleen, brain, bone marrow, and heart (Fig. 7B and
Table 1). On comparing the DNA load in the various organs,
the highest plasmid DNA concentrations were found in liver
(37 pg of plasmid DNA per 250 ng of liver DNA) and lung (31
pg of plasmid DNA per 250 ng of lung DNA) 20 min after jet
injection; these concentrations rapidly dropped within 40 min
of jet injection and were almost completely cleared after 6 hr
(Fig. 7A and Table 1). An almost similar DNA clearance was
observed in the kidneys. Only in one of three animals was a de-
layed clearance observed 3 hr after jet injection (Fig. 7A and
Table 1), whereas at this time point in the kidneys of the other
animals only low amounts of plasmid DNA (0.3 pg of plas-
mid DNA per 250 ng of kidney DNA) were detectable. The
lowest plasmid DNA concentrations were determined in the
brain and heart of the animals (Fig. 7B). Taken together, in all
organs (except blood) the highest plasmid DNA concentrations
were most frequently measured within 40 min of jet injection,
whereas clearance of this DNA was completed as soon as 3 to
6 hr after intratumoral jet injection. This is supported by the
summarized data in Table 1, showing that 6 hr after intratu-
moral jet injection none of the animals tested positively for
pCMV DNA in the organs (except blood).
Analysis of intratumoral and systemic LacZ expression
after jet injection of pCMV plasmid DNA
To determine to what extent jet-injected pCMV plasmid
DNA is transcriptionally active in jet-injected tumors and might
also exert LacZ expression in other sites via systemic distribu-
tion, we tested LacZ mRNA expression in tumors and in or-
gans (blood, liver, lung, kidney, ovary, spleen, brain, bone mar-
row, and heart), using real-time RT-PCR. Table 2 shows that
in jet-injected tumors LacZ mRNA expression is detectable 24
hr after jet injection, reflected by a 322-fold relative expression
level compared with stably LacZ-expressing SW480 calibrator
cells. This mRNA expression remains at a high level 48 hr af-
ter jet injection, followed by a decline in expression level after
72 hr. In addition, the other organs and blood were tested for
LacZ expression at all time points (5, 10, 20, and 40 min and
3, 6, 24, 48, and 72 hr) after jet injection; however, we could
not detect LacZ mRNA at these sites, although the real-time
PCR detected plasmid DNA in all these tissues. Even those or-
gans with the highest pCMV concentrations, such as liver,
lung, and kidney, did not express LacZ-specific mRNA. In fact,
this is a strong indication that systemic biodistribution of in-
tratumorally jet-injected DNA is not associated with transcrip-
tional activity in other sites than the targeted tumor.
FIG. 6. Intracellular distribution of rhodamine-labeled pGeneGRIP plasmid DNA 5, 30, and 60 min after intratumoral jet in-
jection, as analyzed by confocal laser scanning microscopy. (A) Time-dependent distribution of plasmid DNA (red) in the per-
inuclear space and within the cell nuclei (blue) in jet-injected tissues (indicated by arrows). Scale bars: 5 m. (B) A more de-
tailed three-dimensional reconstitution of a z stack acquired by confocal laser microscopy, displaying a tumor cell 5 min after jet
injection with perinuclear and intranuclear localization (arrow) of labeled plasmid DNA (red); nucleus (blue). (C) Quality con-
trol of the nuclear preparation from tumor tissue 60 min after jet injection. Left: Control of nuclear preparation by light mi-
croscopy (nuclei are indicated by arrows). Right: Agarose gel electrophoresis of the pCMV-specific PCR of the washing buffer
of the nuclear pellet (lane 1; lane M, 1-kb DNA ladder) and of the DNA preparation from the nuclei (lane 2). The plasmid-spe-
cific amplicon (127 bp) is indicated. (D) Quantitative real-time PCR analysis of plasmid DNA presence in the nuclei of tumors
5, 30, and 60 min after jet injection, using 250 ng of nuclear DNA.
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DISCUSSION
In this in vivo study we investigated the time course of clear-
ance and biodistribution of naked plasmid DNA applied intra-
tumorally by jet injection. Previous in vivo studies have dem-
onstrated that this nonviral gene transfer technology is efficient
for transfer of various vector constructs in different tissue types,
leading to effective expression of the respective transgenes (Ren
et al., 2002; Walther et al., 2004). Because nothing is known
about the in vivo fate of focally jet-injected naked DNA in tu-
mors or about its systemic biodistribution and clearance, our
study has focused on this issue, using quantitative real-time
PCR. For this we applied 50 g of pCMV DNA by jet injec-
tion, knowing that such dosing had been shown to be effective
for transgene expression in tumor tissue in vivo (Walther et al.,
2001, 2002).
In this study we have shown that shortly after jet injection a
high proportion (more than 70%) of naked DNA is lost in the
tumors. The effect of such rapid losses in DNA has also been
reported in other studies, where naked DNA was applied by
needle injection into muscle, liver, or tumors (Parker et al.,
1999; Dupuis et al., 2000; Herweijer et al., 2001; Cappelletti
et al., 2003; Kawase et al., 2003). Because jet injection applies
only small volumes at high pressure, the potential effect of seep-
age of the jet-injected volume is negligible and does not con-
tribute to quantitative losses of DNA. When correlating this ob-
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FIG. 7. Time-dependent biodistribution of pCMV plasmid DNA in the blood and various organs of animals after intratumoral
jet injection, represented by the highest value of DNA load in the respective organs for each animal group. The plasmid DNA
was quantified by real-time PCR (LightCycler) in each organ, using a spiked plasmid DNA standard curve for each quantifica-
tion analysis. Each time point is represented by the mean value obtained in duplicate in the respective samples. The amounts of
plasmid DNA shown were determined in 250 ng of blood DNA (whole blood) or in the respective organ tissue DNA. (A) Biodis-
tribution in blood, liver, lung, and kidney; (B) biodistribution in ovary, spleen, brain, bone marrow, and heart. The SD was much
less than 10% for all values determined.
servation of rapid decrease in DNA concentration in tumors
with our finding of a significant increase in plasmid DNA in
the blood within 5 min of jet injection, we conclude, that a pro-
portion of jet-injected DNA is dispersed by the blood flow, con-
tributing to the observed intratumoral losses. Such blood-me-
diated dispersion shortly after DNA application has also been
observed by others after intramuscular or intratumoral admin-
istration of plasmid DNA (Parker et al., 1999; Kawase et al.,
2003). Although solid tumors often possess elevated hydrosta-
tic pressure that hinders DNA dispersion, high tumor vascular-
ization with regions of hyperpermeable endothelium might aug-
ment dispersion of jet-injected DNA from the injection site to
the intracellular space (Baban and Seymour, 1998; Pouton and
Seymour, 2001). In addition, degradative processes, such as nu-
clease activities in the target tissue, will contribute to the quan-
titative loss of intact plasmid DNA (Cappelletti et al., 2003;
Walther et al., 2005). We have shown, in a previous study, that
particularly in tumor tissues high nucleolytic activities can be
detected, causing more than 70% DNA degradation within 5 to
10 min of jet injection (Walther et al., 2005). Despite the ob-
served tremendous loss of jet-injected DNA within tumors, pre-
vious studies and this study have demonstrated that the re-
maining small proportions of plasmid DNA (0.07%, 72 hr
after jet injection) lead to transgene expression. In addition, our
detailed analysis of plasmid distribution within tumor tissues
clearly showed that jet injection permits inhomogeneous plas-
mid distribution and does affect the entire tissue (Fig. 4C and
D, and Fig. 5). This represents an important prerequisite for ef-
fective transgene expression within tumors.
To gain more detailed insight into the in vivo path of jet-in-
jected plasmid DNA, particularly shortly after application, we
performed confocal scanning microscopy analysis with rho-
damine-labeled DNA. As we have observed in these analyses,
the majority of labeled DNA was typically localized within the
intercellular space shortly after jet injection, which is in agree-
ment with observations made in another, similar study of naked
DNA gene transfer (Dupuis et al., 2000). More interestingly,
we have seen the rapid entry of labeled DNA into the cyto-
plasm and to a lesser extent into cell nuclei as early as 5 min
after in vivo jet injection, followed by a significant increase in
nuclear accumulation within 30 to 60 min. Regarding this is-
sue, different kinetics of cellular DNA uptake were determined
by other investigators, varying from cytoplasmic uptake in only
a few minutes after application of naked DNA to several hours
(24 hr) in injected muscle or in hepatic tissue after tail vein in-
jection (Budker et al., 2000; Dupuis et al., 2000). Our obser-
vation of plasmid DNA localization in the cytoplasm and cell
nuclei shortly after jet injection might be the result of the high
energy by which jet injection forces DNA into tumor tissue.
Such a mode of application could have similar effects as shown,
for example, in the hydrodynamic procedure leading to tran-
sient close DNA:cell contact as a pressure-dependent effect,
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TABLE 1. MAXIMUM PLASMID DNA LOAD AT THE INDICATED TIME POINTS IN VARIOUS TISSUES OF
ANIMALS AND NUMBER OF TISSUES POSITIVELY TESTED FOR PLASMID DNA FOR EACH TIME POINT




250 ng tissue DNA) at
Organ indicated time (min) 5 minb 10 minb 20 minb 40 minb 3 hrb 6 hrb 24 hrb 48 hrb 72 hrb
Blood 48 (5)0 2/3 3/3 3/3 3/3 3/3 3/3 0/3 0/3 0/3
Liver 37 (20) 3/3 3/3 2/3 1/3 3/3 0/3 0/3 0/3 0/3
Lung 31 (20) 3/3 3/3 2/3 2/3 3/3 0/3 0/3 0/3 0/3
Kidney 26 (40) 3/3 2/3 2/3 2/3 1/3 0/3 0/3 0/3 0/3
Ovary 25 (40) 3/3 3/3 2/3 2/3 3/3 0/3 0/3 0/3 0/3
Spleen 20 (10) 0/3 3/3 3/3 2/3 2/3 0/3 0/3 0/3 0/3
Brain 4 (5) 2/3 2/3 3/3 0/3 3/3 0/3 0/3 0/3 0/3
Heart 03 (40) 3/3 3/3 2/3 2/3 0/3 0/3 0/3 0/3 0/3
Bone marrow 2 (4) 3/3 3/3 2/3 1/3 0/3 0/3 0/3 0/3 0/3
aBoldface indicates groups, all animals of which are negative for plasmid DNA.
bTime after jet injection.
Number of tissues positive for plasmid DNA for each animal group (n  3)
TABLE 2. MAXIMUM RELATIVE LacZ mRNA EXPRESSION LEVEL IN JET-INJECTED
TUMORS COMPARED WITH LacZ EXPRESSION IN STABLY pCMV -TRANSDUCED
SW480 HUMAN COLON CARCINOMA CELL LINEa




Calibrator; data determined by real-time RT-PCR (LightCycler) in duplicate.
which in turn augments cellular DNA uptake (Zhang et al.,
1997). Summarizing these findings, jet injection seems to pos-
itively influence the process of partitioning of plasmid DNA
between the intracellular and intercellular space associated with
any nonviral application of DNA by promoting rapid cellular
uptake and nuclear translocation (Bureau et al., 2004).
Regarding the systemic biodistribution of plasmid DNA, we
detected pCMV DNA in the blood shortly after intratumoral
jet injection; clearance occurred rapidly. Interestingly, this
clearance of DNA from the blood correlated with the increase
in plasmid DNA concentration in those organs particularly
known to be well-vascularized tissues (e.g., liver, lung, and
spleen). Therefore, dispersion of plasmid DNA from the circu-
lation might lead to the observed short and time-restricted ap-
pearance of plasmid DNA in the other organs, which is then
rapidly cleared within 6 hr of jet injection. Interestingly, simi-
lar kinetics of biodistribution for nonvirally applied DNA have
been described by several authors in various in vivo models
(Parker et al., 1999; Kawase et al., 2003; Bureau et al., 2004).
Our observation of complete clearance from all organs within
6 hr of jet injection is important regarding the safety of this
technology. We needed to analyze whether such dispersion of
plasmid DNA might lead to unwanted expression of the trans-
gene. As shown by real-time RT-PCR analysis in all organs, no
such expression was determined at any time. These results give
strong evidence that systemic distribution of plasmid DNA af-
ter intratumoral jet injection is not sufficient to generate gene
transfer and transgene expression outside the actual jet-injected
tumor tissue. One major explanation for this could be that the
major compartment for the biodistribution of plasmid DNA is
the rapidly circulating blood, by which DNA travels from the
tumor to the various organs. It has been suggested, however,
that such systemic DNA distribution occurs with insufficient
time and proximity to the hypothesized DNA receptors on cells
of these organs to permit endocytosis for efficient gene trans-
fer (Liu and Huang, 2002). This is supported by the finding that
occlusion of the blood stream significantly improves gene trans-
fer of naked DNA by increasing the retention time for the DNA
applied (Liu and Huang, 2002). Another explanation for the ab-
sence of gene expression in the various organs is that no phys-
ical energy forces the uptake of naked DNA into the cells of
these organs.
In conclusion, our quantitative and qualitative analysis re-
vealed that the topical application of naked plasmid DNA to tu-
mors leads to efficient gene transfer and transgene expression.
This expression was limited to the primary injection site, despite
the fact that leakage of jet-injected DNA into other organs has
been shown after intratumoral jet injection. In these organs, in
particular, the rapid systemic clearance of plasmid DNA has been
observed. These results support the notion that in vivo jet injec-
tion is a safe nonviral technology for gene therapy approaches.
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